Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RPRX | RVMD | BIIB | ||
| Company | Royalty Pharma Plc Cl A | Revolution Medicines Inc | Biogen Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 54.38 | 160.65 | 200.22 | ||
| High | 54.38 | 164.78 | 200.99 | ||
| Low | 51.15 | 158.40 | 193.20 | ||
| Latest | 52.96 | 162.99 | 196.58 | ||
| Change | -0.74 | +5.22 | -2.09 | ||
| % Change | -1.38% | +3.31% | -1.05% | ||
| Volume | 8,608,500 | 4,702,500 | 1,729,800 | ||
| 20-Day Average Volume | 4,415,180 | 2,988,025 | 1,036,830 | ||
| Previous Close | 53.70 | 157.77 | 198.67 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 54.57 | 154.20 | 195.50 | ||
| 20-Day Raw Stochastic | 33.83% | 85.99% | 62.96% | ||
| 20-Day Relative Strength | 50.48 | 60.90 | 52.91 | ||
| Weighted Alpha | +55.02 | +151.51 | +50.54 | ||
| Today's Opinion | 80% Buy | 100% Buy | 100% Buy | ||
| Previous Opinion | 80% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.21% since 06/11/26 | +9.22% since 06/11/26 | -1.69% since 06/11/26 | ||
| Low | 51.15 on 06/18/26 | 149.67 on 06/12/26 | 193.20 on 06/18/26 | ||
| High | 56.00 on 06/12/26 | 164.78 on 06/18/26 | 203.45 on 06/12/26 | ||
| 1-Month | |||||
| %Chg | +1.71% since 05/18/26 | +12.90% since 05/18/26 | +2.43% since 05/18/26 | ||
| Low | 51.15 on 06/18/26 | 141.44 on 06/10/26 | 184.90 on 06/02/26 | ||
| High | 56.50 on 06/08/26 | 166.50 on 06/01/26 | 203.45 on 06/12/26 | ||
| 3-Month | |||||
| %Chg | +15.66% since 03/18/26 | +66.13% since 03/18/26 | +7.83% since 03/18/26 | ||
| Low | 44.73 on 03/20/26 | 91.52 on 03/30/26 | 168.64 on 04/06/26 | ||
| High | 56.50 on 06/08/26 | 166.50 on 06/01/26 | 205.97 on 05/13/26 | ||
| 6-Month | |||||
| %Chg | +37.81% since 12/18/25 | +114.57% since 12/18/25 | +15.70% since 12/18/25 | ||
| Low | 38.20 on 12/19/25 | 76.28 on 01/05/26 | 160.36 on 01/20/26 | ||
| High | 56.50 on 06/08/26 | 166.50 on 06/01/26 | 205.97 on 05/13/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 30,496,060 | 34,651,024 | 29,022,480 | ||
| Shares Outstanding, K | 575,832 | 212,596 | 147,637 | ||
| Annual Sales | 2,378,190,000 | 0 | 9,890,600,000 | ||
| Annual Net Income | 770,950,000 | -1,131,300,000 | 1,292,900,000 | ||
| Last Quarter Sales | 630,580,000 | 0 | 2,477,800,000 | ||
| Last Quarter Net Income | 294,690,000 | -453,820,000 | 319,500,000 | ||
| 60-Month Beta | 0.43 | 1.40 | 0.20 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.30 on 05/06/26 | -2.29 on 05/06/26 | 3.57 on 04/29/26 | ||
| Earnings Date | 08/05/26 | 08/05/26 | 07/30/26 | ||
| Most Recent Dividend | 0.235 on 05/15/26 | N/A | N/A | ||
| Next Ex-Dividends Date | 05/15/26 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 10.59 | 0.00 | 12.54 | ||